相关实验视频
Updated: Jan 29, 2026

08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
11.2K
基于截断的VZV gE的纳米粒子疫苗在小鼠中引起了强大的免疫反应
Tianxin Shi1,2, Hai Li1, Jiehui Wu1
1National Key Laboratory of Intelligent Tracking and Forecasting for Infections Disease, National Institute for Viral Disease Control and Prevention, Beijing 102206, China.
Vaccines
|January 28, 2026
概括
一种新的疹病毒 (HZ) 纳米粒子疫苗,tgE350 + Fe,在小鼠中显示出增强的免疫反应和安全性. 这种具有成本效益的疫苗可以为预防老年人群VZV重新激活提供一个有希望的替代方案.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 疹疹 (HZ),由疹疹病毒 (VZV) 再激活引起,主要影响老年人.
- 目前的HZ疫苗是有效的,但成本高昂,可能有副作用,需要开发更安全,更实惠的替代品.
- 来自VZV的优化截断gE (tgE350) 作为新型疫苗开发的基础.
研究的目的:
- 使用SpyTag/SpyCatcher技术开发和评估一种新的疹纳米粒子疫苗 (tgE350+Fe).
- 在小鼠模型中评估tgE350 + Fe纳米粒子疫苗的免疫性和安全性.
- 将纳米粒子疫苗诱导的免疫反应与截断蛋白质疫苗进行比较.
主要方法:
- 用SpyTag/SpyCatcher设计的tgE350和Fe蛋白质用于自组装纳米粒子.
- 使用HEK293F和大肠杆菌系统来表达和净化蛋白质;通过电子显微镜证实了纳米粒子的形成.
- 向BALB/c小鼠注射疫苗并评估细胞免疫力 (ELISpot,流细胞计) 和幽默免疫力 (ELISA,中和试验),以及安全性评估.
主要成果:
- 与单独使用tgE350相比,tgE350 + Fe纳米粒子疫苗显著提高了VZV中和抗体和特定抗体反应.
- tgE350 + Fe诱导了更多的分泌IFN-γ,IL-2和IL-4的淋巴细胞,表明细胞免疫力增强.
- 没有观察到淋巴细胞数量或主要器官的病理损伤的显著变化,证明了疫苗的安全性.
结论:
- 成功开发了一种新的疹纳米粒子疫苗,tgE350 + Fe.
- 纳米粒子疫苗在小鼠中显示出增强的VZV特异性中和抗体和优异的细胞和幽默免疫反应.
- tgE350 + Fe疫苗表现出良好的安全性,为预防HZ提供了一个有前途的候选人.
相关概念视频
Vaccinations
51.5K
Overview
51.5K
Humoral Immune Responses
83.8K
Overview
83.8K
Truncation in Survival Analysis
612
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
612
Cell-mediated Immune Responses
84.0K
Overview
84.0K
Cells of the Adaptive Immune Response
8.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.8K
Immune Response Against Viral Pathogens
1.9K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.9K

